CXCL9 antagonism further extends prolonged cardiac allograft survival in CCL19/CCL21-deficient mice

American Journal of Transplantation

Volumn 5, Issue 9, 2005, Pages 2104-2113

  Colvin, Bridget L ^a   Wang, Zhiliang ^a   Nakano, Hideki ^b   Wu, WenHan ^a   Kakiuchi, Terutaka ^c   Fairchild, Robert L ^d   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokines; Dendritic cells; Mouse; Trafficking; Transplant

Indexed keywords

CXCL9 ANTIBODY; CXCL9 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN ANTIBODY; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE MIGRATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECIPIENT; SKIN ALLOGRAFT; T LYMPHOCYTE; TH2 CELL;

ANIMALS; CELL SURVIVAL; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, STATISTICAL; SERINE; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TH2 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 27744485432     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00996.x     Document Type: Article

References (45)

1. Abdi R, Smith RN, Makhlouf L et al. The role of CC chemokine receptor 5(CCR5) in islet allograft rejection. Diabetes 2002; 51: 2489-2495.
2. Yun JJ, Fischbein MP, Laks H et al. Rantes production during development of cardiac allograft vasculopathy. Transplantation 2001; 71: 1649-1656.
3. Segerer S, Cui Y Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531.
4. Agostini C, Calabrese F, Rea F et al. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703-1711.
5. King WJ, Comer RM, Hudde T, Larkin DF, George AJ. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 2000; 70: 1225-1233.
6. Hancock WW, Gao W, Faia KL, Csizmadia V. Chemokines and their receptors in allograft rejection. Curr Opin Immunol 2000; 12: 511-516.
7. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149-155.
8. El-Sawy T, Miura M, Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 2004; 165: 147-157.
9. Kobayashi H, Koga S, Novick AC, Toma H, Fairchild RL. T-cell mediated induction of allogeneic endothelial cell chemokine expression. Transplantation 2003; 75: 529-536.
10. Koga S, Kobayashi H, Novick AC, Toma H, Fairchild RL. Alloantigen-specific CD8(+) T cells stimulate endothelial cells to produce the T-cell chemoattractants IP-10 and Mig. Transplant Proc 2001; 33: 459-460.
11. Kapoor A, Morita K, Engeman TM et al. Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells. Transplantation 2000; 69: 1147-1155.
12. Kondo T, Morita K, Watarai Y et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69: 969-977.
13. Miura M, Morita K, Kobayashi H et al. Monokine induced by IFNγ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001; 167: 3494-3504.
14. Kobayashi H, Novick AC, Toma H, Fairchild RL. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts. Transplantation 2002; 74: 387-395.
15. Gunn MD, Kyuwa S, Tam C et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189: 451-460.
16. Nakano H, Tamura T, Yoshimoto T et al. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur J Immunol 1997; 27: 215-221.
17. Nakano H, Mori S, Yonekawa H, Nariuchi H, Matsuzawa A, Kakiuchi T. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood 1998; 91: 2886-2895.
18. Nakano H, Gunn MD. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J Immunol 2001; 166: 361-369.
19. Vassileva G, Soto H, Zlotnik A et al. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J Exp Med 1999; 190: 1183-1188.
20. Cravens PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 2002; 80: 497-505.
21. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14: 129-135.
22. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A 2000; 97: 12694-12699.
23. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-242.
24. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol 1994; 1: 229-246.
25. Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998; 188: 181-191.
26. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225-229.
27. Mayumi H, Nomoto K, Good RA. A surgical technique for experimental free skin grafting in mice. Jpn J Surg 1988; 18: 548-557.
28. Yoshino M, Yamazaki H, Nakano H et al. Distinct antigen trafficking from skin in the steady and active states. Int Immunol 2003; 15: 773-779.
29. - dendritic cells and their in vivo trafficking. J Leukoc Biol 2004; 75: 275-285.
30. Ritter U, Wiede F, Mielenz D, Kiafard Z, Zwirner J, Korner H. Analysis of the CCR7 expression on murine bone marrow-derived and spleen dendritic cells. J Leukoc Biol 2004; 76: 472-476.
31. + dendritic cell subsets to traverse endothelium is not determined by differential CD11b expression. Immunology 2004; 113: 328-337.
32. Merad M, Fong L, Bogenberger J, Engleman EG. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo. Blood 2000; 96: 1865-1872.
33. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686-688.
34. Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H, Fairchild RL. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFNγ-induced chemokine Mig. J Immunol 1999; 163: 4878-4885.
35. Sallusto F. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Haematologica 1999; 84: 28-31.
36. Yoneyama H, Matsuno K, Zhang Y et al. Evidence for recruitment of plasmactyoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004; 16: 915-928.
37. Fairchild RL, Kobayashi H, Miura M. Chemokines and the recruitment of inflammatory infiltrates into allografts. Graft 2000; 3(3 Suppl 1): S24-S31.
38. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. Mice lacking expression of the chemokines CCL21-ser and CCL19(plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 2001; 193: 207-218.
39. + T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002; 8: 234-239.
40. Park MK, Amichay D, Love P et al. The CXC chemokine murine monokine induced by IFNγ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 2002; 169: 1433-1443.
41. + T cell differentiation and bridges central and peripheral functions. J Immunol 2003; 171: 2812-2824.
42. Hopken UE, Droese J, Li JP et al. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses. Eur J Immunol 2004; 34: 461-470.
43. Beckmann JH, Van S, Luhrs H et al. Prolongation of allograft survival in CCR7-deficient mice. Transplantation 2004; 77: 1809-1814.
44. Junt T, Nakano H, Dumrese T et al. Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J Immunol 2002; 168: 6032-6040.
45. Junt T, Scandella E, Forster R et al. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. J Immunol 2004; 173: 6684-6693.